These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18351152)
1. [Risedronate (Actonel)--from randomized clinical trials to real life]. Anić B Reumatizam; 2007; 54(2):85-6. PubMed ID: 18351152 [No Abstract] [Full Text] [Related]
2. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study. Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280 [TBL] [Abstract][Full Text] [Related]
3. Monthly risedronate (Actonel) for postmenopausal osteoporosis. Med Lett Drugs Ther; 2008 Sep; 50(1294):69-70. PubMed ID: 18772843 [No Abstract] [Full Text] [Related]
4. [Men also need bone protection]. MMW Fortschr Med; 2006 Nov; 148(46):48-9. PubMed ID: 17615790 [No Abstract] [Full Text] [Related]
5. [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice]. MMW Fortschr Med; 2007 Mar; 149(13):50. PubMed ID: 17672400 [No Abstract] [Full Text] [Related]
6. [Correlation between studies and general practice]. MMW Fortschr Med; 2006 Nov; 148(46):49. PubMed ID: 17615791 [No Abstract] [Full Text] [Related]
7. [What do we need to know--what can we do?]. Krankenpfl J; 2005; 43(7-10):217. PubMed ID: 16515289 [No Abstract] [Full Text] [Related]
8. When do bisphosphonates make the most sense? Winzenberg T; Jones G J Fam Pract; 2011 Jan; 60(1):18-28. PubMed ID: 21209974 [No Abstract] [Full Text] [Related]
9. [Postmenopausal osteoporosis. Bisphosphonates are not all equal]. MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206 [No Abstract] [Full Text] [Related]
10. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis. Eastell R; Hannon RA; Garnero P; Campbell MJ; Delmas PD J Bone Miner Res; 2007 Nov; 22(11):1656-60. PubMed ID: 17931100 [No Abstract] [Full Text] [Related]
12. [Your patients face the treatment of osteoporosis: How to improve the efficacy of management in clinical practice?]. Thomas T; Reach G; Lespessailles E Rev Prat; 2006 Jan; Spec No():3-11. PubMed ID: 16502833 [No Abstract] [Full Text] [Related]
13. One drug tackles two diseases. Br Dent J; 2005 Dec; 199(11):701. PubMed ID: 16341176 [No Abstract] [Full Text] [Related]
14. Risedronate for the prevention of fractures in postmenopausal osteoporosis. Sickels JM; Nip CS Ann Pharmacother; 2002 Apr; 36(4):664-70. PubMed ID: 11918518 [TBL] [Abstract][Full Text] [Related]
15. [To treat effectively without delay. The data on fractures decisive]. MMW Fortschr Med; 2003 May; 145(21):56-7. PubMed ID: 12845873 [No Abstract] [Full Text] [Related]
17. Once-a-week risedronate (actonel). Med Lett Drugs Ther; 2002 Oct; 44(1141):87-8. PubMed ID: 12381968 [No Abstract] [Full Text] [Related]
18. Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective. Wasserfallen JB; Krieg MA; Greiner RA; Lamy O J Med Econ; 2008; 11(3):499-523. PubMed ID: 19450101 [TBL] [Abstract][Full Text] [Related]
19. [Risedronate for treatment of osteoporosis]. Hagino H Nihon Rinsho; 2009 May; 67(5):948-53. PubMed ID: 19432115 [TBL] [Abstract][Full Text] [Related]
20. [Evidence of risedronate for treatment of osteoporosis]. Soen S Nihon Rinsho; 2007 Nov; 65 Suppl 9():344-7. PubMed ID: 18161128 [No Abstract] [Full Text] [Related] [Next] [New Search]